OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study

CLINICAL CANCER RESEARCH

Kandimalla, R; Wang, W; Yu, F; Zhou, NX; Gao, F; Spillman, M; Moukova, L; Slaby, O; Salhia, B; Zhou, ST; Wang, X; Goel, A, 2021: OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study. CLINICAL CANCER RESEARCH 27(15), p. 4277 - 4286, doi: 10.1158/1078-0432.CCR-21-0267

Research Groups:

• Molecular Oncology - Solid Cancer - Ondřej Slabý

CEITEC authors:

• Prof. Ondřej Slabý, Ph.D.